Skip to main content
. 2022 May 4;2022:8536149. doi: 10.1155/2022/8536149

Table 2.

Summary of studies showing improvement of breast implant illness symptoms with explantation.

Author, year Study type Patients/studies Findings
Maijers et al. [2], Neth J Med, PMID: 24394743 Descriptive cohort study n = 80 women with SBIs and subsequent onset of unexplained symptoms After explantation, 36/52 (69%) women with systemic symptoms experienced significant reduction in symptoms
Colaris et al. [7], Immunol Res., PMID: 27406737 Comparative study n = 100 patients diagnosed in 2014 with ASIA 54 patients underwent explantation, of which 27 (50%) experienced improvement of complaints
de Boer et al. [5], Immunol Res., PMID: 27412295 Systematic review 23 studies were analyzed, N = 622 patients who underwent explantation of breast implants Explantation improved complaints in 469 of 622 (75%) patients.
In patients with autoimmune diseases, additional immunosuppressive therapy increased improvement
Lee et al. [36], Plast Reconstr Surg Glob Open, PMID: 32440423 Prospective cohort study n = 50 patients with BII Explantation improved or resolved some symptoms in 39 out of 44 patients (78%)
Wee et al. [73], Ann Plast Surg, PMID 32530850 Retrospective cohort study n = 552 women with SBIs undergoing explantation with post-operative symptom follow-up Improvement across 11 common symptom domains following removal of breast implants and total capsulectomy
Glicksman et al. [72], Aesthetic Surg J, PMID: 34915566 Prospective cohort study n = 150 women undergoing explantation of SBIs versus women undergoing mastopexy Symptoms of BII significantly improved for greater than 6 months in women undergoing explantation of SBI
Katsnelson et al. [39], Plast Reconst Surg Glob Open, PMID 34513545 Retrospective cohort study n = 248 women with SBIs undergoing explantation Of 46 women who responded to postoperative symptom follow-up, 96% reported improvement in symptoms